Chronic Constipation: Lecicarbon® Treatment Study

We are evaluating the safety and tolerability of long-term treatment with Lecicarbon® for people with chronic constipation. This study aims to understand how well patients can manage this treatment over time.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Lecicarbon E Co2-Laxans
Lecicarbon E Co2-Laxans is a medicine used to relieve constipation.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Sodium Dihydrogen Phosphate
Sodium dihydrogen phosphate is a phosphate salt used to replenish low phosphate levels and to help cleanse the bowel before medical procedures.
Sodium Hydrogen Carbonate
Sodium hydrogen carbonate is a substance that neutralizes excess stomach acid to relieve heartburn and indigestion.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Accusol 35
Accusol 35 Kalium
Accusol 35 Potassium

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
medicoKIT GmbH
medicoKIT
Goch, Germany
Sponsor: Athenstaedt GmbH & Co. KG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.